NCT06429891View on ClinicalTrials.gov

Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization

NARecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Solid Tumor

Interventions

DRUG

18F-FDG

All study participants will undergo one 18F-FDG PET/CT scan.

Trial Locations (1)

100142

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Hua Zhu

OTHER